Back
Business
-
Briefly
CHENNAI: Shasun Chemicals has entered into a non-exclusive licensing agreement with Merck & Co of the U.S. Under the agreement, Shasun grants Merck the use of its proprietary cross-coupling copper technology to manufacture and commercialise active pharmaceutical ingredients (APIs). — Corporate Reporter © Copyright 2000 - 2009 The Hindu |